November 2021 Addex's strategic partner The Janssen Pharmaceutical Companies of Johnson & Johnson, Inc today announced that Janssen Pharmaceuticals, Inc., part of the Janssen Pharmaceutical Companies of Johnson & Johnson, has successfully completed Phase 1 studies in Japan with JNJ-40411813 (ADX71149).

Elizabeth Johnstone were awarded one of the 2022 Diabetes Research Grants at the World Diabetes Day Breakfast "Congratulations to Perkins Professor Kevin Pfleger and Dr Elizabeth Johnstone who were awarded one of

Previous companies worked at include OrthoBiotech (OBI), a division of Johnson & Johnson and GlaxoSmithKline

It began in Bari, Italy, with a love for science nurtured by her father and fueled by childhood cartoons

Anthony Johnson as President/CEO! Save the dates: February 8 - 29: Join Dr.

Prézeau, for their research on Heterodimers revolutionize the field of metabotropic glutamate receptors Kara

where different ligands acting on the same receptor trigger distinct signaling pathways, leading to varied Cary, B.P., et al., New Insights into the Structure and Function of Class B1 GPCRs.  

Celtarys’ technology significantly reduces the time it takes to obtain fluorescent tags and test varying A.; Johnstone, E. K. M.; Wheal, A. J.; Goulding, J.; Robers, M. B.; Machleidt, T.; Wood, K.

agonists of FFAR4 for type 2 diabetes mellitus therapy Industry News OMass Therapeutics Welcomes Melissa Faris

strand align well, although the position of the disulfide bridges between the N-loop and the 30s-loop varies stability of the salt bridge depends on the position of NH2, which is most stable at position 1 (Wasilko, Johnson

.; Johnsson, K. doi.org/10.1038/nmeth.1213 . (23)      Keppler, A.; Gendreizig, S.; Gronemeyer, T.; Pick, H.; Vogel, H.; Johnsson